Article Sidebar

PDF
Date Published: 13/01/2022
Abstract Views: 1186
Views PDF: 647
DOI: https://doi.org/10.51298/vmj.v509i2.1844
Issue
Vol. 509 No. 2 (2021)
Section
Các bài báo
How to Cite
Văn Dũng, T. ., Hồng Huy, L. ., & Đức Tuấn, N. . (2022). DIRECT COST OF HER2-POSITIVE BREAST CANCER TREATMENT AT K HOSPITAL 2020. Vietnam Medical Journal, 509(2). https://doi.org/10.51298/vmj.v509i2.1844

DIRECT COST OF HER2-POSITIVE BREAST CANCER TREATMENT AT K HOSPITAL 2020

Trần Văn Dũng1,, Lưu Hồng Huy1, Nguyễn Đức Tuấn1
1 K Hospital

Main Article Content

Abstract

Objective: To determine the direct cost of inpatient treatment of patients with HER2-positive breast cancer at K Hospital in 2020. Subject: Records of 80 patients' medical records, who were diagnosed with HER2+ breast cancer and treated at K Hospital in 2020. Data is stored on the management software of K Hospital. Method: A cross-sectional descriptive study. Result and conclusion: The study showed that the direct cost of treating HER2-positive breast cancer patients in one session was 20.010.000 VNĐ with the lowest of 1.034.000 VNĐ and the highest cost of 97.852.000 VNĐ. Health insurance coverage is over 60% of total direct costs among insured patients. Direct treatment costs tend to increase as the stage of the disease increases.

Article Details

Keywords

HER2-positive breast cancer, direct treatment costs

References

1. Globocan, 2021, truy cập ngày 01/03/2021,
“https://gco.iarc.fr/today/data/factsheets/populations/704-viet-nam-fact-sheets.pdf”.
2. Loibl, S. and Gianni, L., 2017. HER2-positive breast cancer. The Lancet, 389(10087), trang 2415-2429.
3. Dolan, P., Torgerson, D. J., & Wolstenholme, J. (1999). Costs of breast cancer treatment in the United Kingdom. The breast, 8(4), trang 205-207.
4. Nguyễn, T. T. T., & Nguyễn, V. H. (2014). Đánh giá gánh nặng kinh tế của ung thư vú tại Việt Nam, Kỷ yếu hội nghị khoa học công nghệ tuổi trẻ các Trường Đại học & Cao đẳng 2014, trang 838-843.
5. Mahar, A.L., N.G. Coburn, and A.P. Johnson, 2014, A population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer. Lung Cancer, 86(2): trang 281-7.
6. Corral, J., Espinàs, J.A., Cots, F., Pareja, L., Solà, J., Font, R. and Borràs, J.M., 2015. Estimation of lung cancer diagnosis and treatment costs based on a patient-level analysis in Catalonia (Spain). BMC health services research, 15(1), trang.1-10.
7. Nguyễn Quỳnh Anh và Nguyễn Thu Hà, 2021, Chi phí trực tiếp điều trị ung thư vú tại Việt Nam năm 2019, Tạp chí Y học Việt nam, 502 (2).
8. Nguyễn Thị Mai, Lan, 2021. Nghiên cứu tỷ lệ mắc mới ung thư vú ở phụ nữ Hà Nội giai đoạn 2014-2016 (Doctoral dissertation).
9. Nguyễn Thị Thu Thuỷ và Nguyễn Văn Hà, 2014. Đánh giá gánh nặng kinh tế của ung thư vú tại Việt Nam.